Navigation Links
Study of DuraPrep versus chlorhexidine
Date:10/9/2009

3M Health Care today announced the publication of a new independent study "Effects of Preoperative Skin Preparation on Postoperative Wound Infection Rates: A Prospective Study of 3 Skin Preparation Protocols," that compared the effects of three different skin preparation solutions on surgical-site infections. The study found that Iodophor-based skin preparation solutions, such as 3M DuraPrep Surgical Solution (Iodine Povacrylex [0.7% available Iodine] and Isopropyl Alcohol, 74% w/w) Patient Preoperative Skin Prep, may be superior to chlorhexidine in preventing surgical-site infections.

Authored by Brian R. Swenson, MD, Robert G. Sawyer, MD, and colleagues from the University of Virginia Health System in Charlottesville, VA, the study appears in the October 2009 issue of the journal Infection Control and Hospital Epidemiology.

The study, which examined more than 3,200 general surgery patients during an 18-month period, was performed in concert with ongoing data collection for the American College of Surgeons' National Surgical Quality Improvement Project (NSQIP). This program, which employs a prospective, peer-controlled, validated database to quantify 30-day risk-adjusted surgical outcomes, is a tool to measure and report surgical quality and outcomes and is recognized by the Institutes of Medicine, the Joint Commission and the American Board of Surgery.

"The main findings of the study were somewhat unexpected. Based on data derived from central venous catheter insertions, we had thought that the infection rates would be lowest in the period where chlorhexidine was the preferred agent for skin preparation. This was not the case. If these findings are reproduced in a multicenter study, switching to iodine-based preparations on a broad basis could significantly reduce the huge morbidity and cost associated with surgical site infection in this country and abroad," said Robert G. Sawyer, M.D., Professor of Surgery and Public Health Science, Co-director Surgical Trauma Intensive Care Unit and Director of Surgical Nutrition Services at the University of Virginia Health System and co-author on the study.

"To date, there have only been limited studies comparing the impact of various skin preparation solutions on surgical-site infections. Previous studies examined only specific surgical sites or relied on less impactful surrogate endpoints such as microbial counts. Dr. Sawyer's study provided a broader assessment of general surgery patients and specifically examined means to reduce the risk of surgical-site infections," said Debra Rectenwald, Vice President and General Manager 3M Infection Prevention Division, 3M Health Care. "We are pleased that DuraPrep solution has been proven effective in the fight against surgical-site infections, and that hospitals, like the University of Virginia Health System, are updating their protocols to include its use."


'/>"/>

Contact: Molly Rabinovitz
mrabinovitz@wcpglobal.com
312-646-6294
WeissComm Partners
Source:Eurekalert

Related medicine news :

1. Researchers report benefits of new standard treatment study for rare pediatric brain cancer
2. Feinstein Investigators Receive Federal GO Grant to Study the Genetics of Schizophrenia
3. Miscarriage Treatment Wont Harm Future Fertility: Study
4. Shingles Raises Stroke Risk: Study
5. Major health care challenges persist for D.C. children despite high rates of health insurance coverage, RAND study finds
6. Radiation costs vary widely by delivery, U-M study finds
7. A study to prevent sudden death in sports by means of genetic testing
8. International Study Finds New Best Practices to Reduce Fire Casualties
9. Long-Term Back Pain Not Inevitable, Study Finds
10. Birth Control Pills Might Alter Mate Selection: Study
11. Rare head and neck cancer linked to HPV, study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2016)... ... December 10, 2016 , ... The ... PATS recently joined forces with other healthcare organizations to promote diabetes education at ... in Harrisburg, featured a variety of speakers from around the Commonwealth of Pennsylvania. ...
(Date:12/9/2016)... , ... December 09, 2016 , ... ... and aural rehabilitation—provided by audiologists—to remain a critical part of public access to ... Drug Administration (FDA) announced this week that, starting immediately, it would ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... miniature, folded, pharmaceutical inserts and outserts. As a means of expanding capabilities ... addition will enable Flottman to individually code professional inserts (PIs) and patient package ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... its 10th anniversary with the grand opening of the Sober College Robert Pfeifer ... spanned two days, December 2-3, and was attended by an overwhelming amount of ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... Ball at The Pierre Hotel in New York, NY, on December 3rd, to ... dignitaries and physicians attended the annual event, which raised over $1 million - ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)...  Eli Lilly and Company (NYSE: LLY ... EXPEDITION3 trial at the 9 th Clinical Trials ... did not meet the primary endpoint in the EXPEDITION3 ... with mild dementia due to Alzheimer,s disease (AD), and ... the treatment of mild dementia due to AD. ...
(Date:12/8/2016)... QUEBEC CITY , Dec. 8, 2016 /PRNewswire/ ... key US patents for improving the accuracy, reproducibility ... CD images in long and small bone orthopaedic ... proprietary approach to creating personalized orthopaedic restorations based ... create personalized orthopaedic restorations, the company harnesses the ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, ... has obtained proof-of-mechanism for neflamapimod (previously code named ... Phase 2a clinical trials that demonstrated significant Alzheimer,s ... 302 (12-week treatment) and Study 303 (6-week treatment) ... Trials in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: